Dose-Response Relationship between Post-Progression Bevacizumab Exposure and Survival among Metastatic Colorectal Cancer Patients

被引：0
|
作者：
Flick, E. Dawn [1 ]
Barr, Charles E. [1 ]
Fish, Susan M. [1 ]
Leon, Larry F. [1 ]
Mun, Yong [1 ]
Dalal, Darshan [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
520
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [41] Dose-response relationship between coffee and the risk of pancreas cancer
    Nishi, M
    Ohba, S
    Hirata, K
    Miyake, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (01) : 42 - 48
  • [42] DOSE-RESPONSE RELATIONSHIP BETWEEN INOCULUM DOSE OF ANTHRAX SPORES AND SURVIVAL TIME OF MICE
    SETO, K
    TAKIZAWA, T
    NATIONAL INSTITUTE OF ANIMAL HEALTH QUARTERLY, 1969, 9 (03) : 129 - &
  • [43] Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study
    Grothey, Axel
    Flick, E. Dawn
    Cohn, Allen L.
    Bekaii-Saab, Tanios S.
    Bendell, Johanna C.
    Kozloff, Mark
    Roach, Nancy
    Mun, Yong
    Fish, Susan
    Hurwitz, Herbert I.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (07) : 726 - 734
  • [44] Dose-response relationship between hand-arm vibration exposure and vibrotactile thresholds among roadworkers
    Clemm, Thomas
    Faerden, Karl
    Ulvestad, Bente
    Lunde, Lars-Kristian
    Nordby, Karl-Christian
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2020, 77 (03) : 188 - 193
  • [45] Dose-Response Relationship Between Exposure to Hand-arm Vibration and Health Effects among Metalworkers
    Sauni, Riitta
    Paakkonen, Rauno
    Virtema, Pauliina
    Toppila, Esko
    Uitti, Jukka
    ANNALS OF OCCUPATIONAL HYGIENE, 2009, 53 (01): : 55 - 62
  • [46] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [47] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [48] Assessment of exposure-response relationship for cetuximab in patients with metastatic colorectal cancer and head and neck cancer
    Pena-Cabia, Silvia
    Royuela-Vicente, Ana
    Ramos-Diaz, Ruth
    Gutierrez-Nicolas, Fernando
    Garcia-Diaz, Benito
    Lopez-Martin, Ana
    FARMACIA HOSPITALARIA, 2022, 46 (01) : 21 - 26
  • [49] Post-progression survival of patients with metastatic hormone-sensitive prostate cancer (mHSPC) who received darolutamide or placebo: Post hoc analysis of ARASENS
    Grimm, Marc-Oliver
    Smith, Matthew Raymond
    Hussain, Maha H. A.
    Saad, Fred
    Fizazi, Karim
    Littleton, Natasha
    Paracha, Noman
    Srinivasan, Shankar
    Verholen, Frank
    Tombal, Bertrand F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Effect of the addition of bevacizumab to first-line FOLFOX on efficacy, including response rate, progression-free survival, and overall survival, in patients with metastatic colorectal cancer
    Suenaga, M.
    Mizunuma, N.
    Matsusaka, S.
    Shinozaki, E.
    Ogura, M.
    Kuboki, Y.
    Watanabe, T.
    Ozaka, M.
    Chin, K.
    Hatake, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345